Detroit stem cell startup MitoStem has received a $200,000 Small Business Innovation Research (SBIR) Phase I grant from the National Institutes of Health, according to an announcement by TechTown, the incubator that houses the company near the campus of Wayne State University. MitoStem is enrolled in TechTown’s SmartStart business accelerator program. The grant will allow MitoStem to develop new stem cell lines and enable creation of stem cells from a patient’s own cells for replacement of diseased and damaged tissues, according to the company.
Author: Howard Lovy
Howard Lovy is a veteran journalist who has focused primarily on technology, science and innovation during the past decade.
In 2001, he helped launch Small Times Magazine, a nanotech publication based in Ann Arbor, MI, where he built the freelance team and worked closely with writers to set the tone and style for an emerging sector that had never before been covered from a business perspective. Lovy's work at Small Times, and on one of the first nanotechnology-themed blogs, helped him earn a reputation for making complex subjects understandable, interesting, and even entertaining for a broad audience. It also earned him the 2004 Prize in Communication from the Foresight Institute, a nanotech think tank.
In his freelance work, Lovy covers nanotechnology in addition to technological innovation in Michigan with an emphasis on efforts to survive and retool in the state's post-automotive age. Lovy's work has appeared in many publications, including Wired News, Salon.com, the Wall Street Journal, The Detroit News, The Scientist, the Forbes/Wolfe Nanotech Report, Michigan Messenger, and the Ann Arbor Chronicle.
View all posts by Howard Lovy